⌘K

17:37:22·479d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13D/A filed by Omega Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.

OMGA· Omega Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

OMGA
Omega Therapeutics Inc.
Health Care

Recent analyst ratings

Nov 15UpdateRaymond James-
Jun 18UpdateRaymond James$12.00
May 25UpdateJefferies$15.00
Dec 8UpdateH.C. Wainwright$11.00
Sep 23UpdateChardan Capital Markets$12.00
Aug 24UpdateWedbush$36.00

Related

SEC394d
SEC Form EFFECT filed by Omega Therapeutics Inc.
SEC399d
SEC Form POS AM filed by Omega Therapeutics Inc.
SEC399d
SEC Form S-8 POS filed by Omega Therapeutics Inc.
SEC400d
SEC Form 25 filed by Omega Therapeutics Inc.
SEC413d
Amendment: SEC Form SCHEDULE 13G/A filed by Omega Therapeutics Inc.
SEC424d
SEC Form 8-K filed by Omega Therapeutics Inc.
SEC434d
Omega Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation
SEC443d
Amendment: SEC Form SCHEDULE 13D/A filed by Omega Therapeutics Inc.